Gel Microspheres as Multifunctional Carriers for Photodynamic Therapy: Advancing Hepatocellular Carcinoma Treatment.
1/5 보강
Conventional hepatocellular carcinoma (HCC) treatments suffer from insufficient efficacy and severe toxic side effects.
APA
Fan S, Ye Q, et al. (2026). Gel Microspheres as Multifunctional Carriers for Photodynamic Therapy: Advancing Hepatocellular Carcinoma Treatment.. Gels (Basel, Switzerland), 12(3). https://doi.org/10.3390/gels12030214
MLA
Fan S, et al.. "Gel Microspheres as Multifunctional Carriers for Photodynamic Therapy: Advancing Hepatocellular Carcinoma Treatment.." Gels (Basel, Switzerland), vol. 12, no. 3, 2026.
PMID
41892537
Abstract
Conventional hepatocellular carcinoma (HCC) treatments suffer from insufficient efficacy and severe toxic side effects. This review addresses these issues by focusing on gel microsphere-mediated photodynamic therapy (PDT) as a novel strategy. It outlines the core properties, classifications, and stimulus-responsive mechanisms of gel microspheres, as well as their structure-function compatibility with photosensitizers. The work highlights how gel microspheres enable targeted delivery, tumor microenvironment-responsive release, and synergistic effects with chemotherapy, radiotherapy, and immunotherapy to enhance therapeutic efficacy while reducing off-target damage. Additionally, it discusses current challenges including material parameter controllability and clinical translation hurdles, providing insights for the development of precise and personalized HCC treatments.
🏷️ 키워드 / MeSH
같은 제1저자의 인용 많은 논문 (5)
- Integrative multiomics dissection of LSM7 as a prognostic biomarker and therapeutic target in hepatocellular carcinoma.
- Roles and clinical translational prospects of TMEM proteins in the tumor immune microenvironment.
- A Nomogram to Predict Non-Sentinel Axillary Lymph Node Metastases in Breast Cancer Patients With Negative or Positive Sentinel Lymph Node Results.
- Association between serum uric acid levels and clinical outcomes of immunotherapy in advanced colorectal cancer patients.
- Cyclophosphamide alters gut microbiota metabolism and structure in lymphoma-bearing mice: implications for dietary modulation.